Blood Collection Biorepository for Liver Disease Research
This study is creating a collection of blood samples (a biorepository) from people with different liver conditions like Non-Alcoholic Steatohepatitis (NASH), Hepatitis C, Hepatitis B, fibrosis, and cirrhosis, as well as from people without liver disease. The goal is to provide high-quality samples to researchers studying how fatty liver and viral diseases affect the liver. This will help them make new discoveries and improve treatments. You can join if you are 7 years or older and have a liver disease or are a healthy control. The study aims to collect 1000 samples over 52 weeks.
- Study design
- This is an observational study, meaning researchers will collect samples and information without giving any specific treatments. It aims to enroll 1000 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, number of samples collected, is measured at 52 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Blood Collection Biorepository for Liver Disease Research
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Andrew Talal, MD · PRINCIPAL_INVESTIGATOR · University at Buffalo
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Number of samples collected52 weeks
Total number of samples collected